Đang chuẩn bị liên kết để tải về tài liệu:
Clinical PET and PET/CT

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The field of molecular imaging/nuclear medicine continues to build excitement for the medical community as a whole. To be able to visualize fundamental molecular and biochemical processes in patients in a meaningful way has truly become reality. Of all the available molecular probes and tools it is clear that FDG with PET-CT is one of the true clinical success stories. Very few would have been able to predict the eventual impact of a simple glucose analog as a marker for imaging cancer, hibernating myocardium, Alzheimer’s disease, epilepsy and many other important disease processes

TÀI LIỆU LIÊN QUAN

Clinical PET and PET/CT

PET in the Evaluation of Alzheimer’s Disease and Related Disorders

Positron Emission Tomography

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: A retrospective study

A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis

The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): A pragmatic phase III randomized controlled trial

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: A retrospective single center study

PET/CT in Clinical Practice
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.